Complete Filing Data
Scientist Home Future Health Ltd reported Stockholders Equity of $113.4 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Scientist Home Future Health Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income * | -$231.7K |
| Cost of Revenue * | $1.1K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$2.9K |
| Selling General And Administrative Expense | $313.6K |
| Operating Income Loss | -$231.7K |
| Income Tax Expense Benefit | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$231.7K |
| Gross Profit | $81.9K |
| Comprehensive Income Net Of Tax | -$234.6K |
| Revenues | |
| Income Taxes Paid Net | $0.00 |
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | -$16.6K |
| Revenue For Service | $6.6K |
| Retail Trading Revenue | $197.4K |
| Cost Of Retail Trading Revenue | $121.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Net Income * | -$47.8K | -$37.2K | $6.1K | $175.00 |
| Cost of Revenue * | $23.5K | $18.0K | $25.1K | $33.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$2.2K | $219.00 | -$12.00 | $0.00 |
| Selling General And Administrative Expense | $63.9K | $51.7K | $12.7K | $24.5K |
| Operating Income Loss | -$47.8K | -$38.1K | $7.0K | $1.9K |
| Income Tax Expense Benefit | $0.00 | -$935.00 | -$935.00 | $1.8K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$47.8K | -$38.1K | $7.0K | $1.9K |
| Gross Profit | $16.1K | $13.5K | $19.7K | $26.4K |
| Comprehensive Income Net Of Tax | -$50.0K | -$37.0K | $6.0K | $175.00 |
| Revenues | $39.6K | $31.6K | $44.8K | $59.4K |
| Income Taxes Paid Net | $0.00 | $0.00 | ||
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | -$10.9K | -$9.6K | ||
| Revenue For Service | ||||
| Retail Trading Revenue | ||||
| Cost Of Retail Trading Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | $113.4K | -$6.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $68.9K | $18.6K |
| Assets | $644.4K | $21.2K |
| Taxes Payable Current | $1.8K | $1.8K |
| Retained Earnings Accumulated Deficit | -$246.7K | -$15.0K |
| Liabilities Current | $214.5K | $27.3K |
| Liabilities And Stockholders Equity | $644.4K | $21.2K |
| Liabilities | $531.0K | $27.3K |
| Inventory Net | $34.0K | $2.6K |
| Common Stock Value | $2.4K | $2.3K |
| Assets Current | $192.2K | $21.2K |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.9K | $0.00 |
| Accounts Payable And Accrued Liabilities Related Party | $78.3K | $4.2K |
| Accounts Payable And Accrued Liabilities Current | $44.6K | $15.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations | $50.3K | |
| Separate Account Liability Increase Decrease From Other Change | $13.1K | |
| Operating Lease Right Of Use Asset Amortization Expense | $24.8K | |
| Operating Lease Right Of Use Asset | $378.9K | $0.00 |
| Operating Lease Liability Noncurrent | $316.5K | $0.00 |
| Operating Lease Liability Current | $74.2K | $0.00 |
| Liabilities Noncurrent | $316.5K | $0.00 |
| Deposits Assets Current | $89.4K | $0.00 |
| Assets Noncurrent | $452.1K | $0.00 |
| Subscription Receivable | ||
| Property Plant And Equipment Net | $73.2K | $0.00 |
| Operating Leases Liability Noncurrent | $11.4K | |
| Operating Leases Liability Current | $22.0K | |
| Non Cash Transaction Initial Recognition Of Operating Lease Right Of Use Assets And Operating Lease Obligations | $403.8K | |
| Non Cash Transaction Finance Lease Liabilities Initial Recognition Of The Balance Payment Of Finance Lease Right Of Use Asset | $0.00 | |
| Lease Right Of Use Asset | $33.4K | |
| Initial Recognition Of Operating Lease Right Of Use Assets And Operating Lease Obligations | ||
| Finance Lease Liabilities Initial Recognition Of The Balance Payment Of Finance Lease Right Of Use Asset |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|
| Stockholders Equity | $267.0K | $51.5K | $27.00 | $9.1K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $275.6K | $111.4K | $16.1K | $19.0K | |
| Assets | $723.0K | $114.7K | $19.6K | $46.4K | |
| Taxes Payable Current | $1.8K | $1.8K | $2.8K | ||
| Retained Earnings Accumulated Deficit | -$94.0K | -$46.1K | -$8.9K | ||
| Liabilities Current | $123.4K | $63.2K | $19.6K | ||
| Liabilities And Stockholders Equity | $723.0K | $114.7K | $19.6K | ||
| Liabilities | $456.0K | $63.2K | $19.6K | ||
| Inventory Net | $2.0K | $3.3K | $3.5K | ||
| Common Stock Value | $2.4K | $2.4K | $2.3K | ||
| Assets Current | $325.7K | $114.7K | $19.6K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.0K | $207.00 | -$12.00 | ||
| Accounts Payable And Accrued Liabilities Related Party | $41.0K | $37.4K | $6.6K | ||
| Accounts Payable And Accrued Liabilities Current | $5.1K | $16.1K | $4.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations | $19.0K | ||||
| Separate Account Liability Increase Decrease From Other Change | $0.00 | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $0.00 | ||||
| Operating Lease Right Of Use Asset | $397.3K | ||||
| Operating Lease Liability Noncurrent | $332.6K | ||||
| Operating Lease Liability Current | $67.6K | ||||
| Liabilities Noncurrent | $332.6K | ||||
| Deposits Assets Current | $48.1K | ||||
| Assets Noncurrent | $397.3K | ||||
| Subscription Receivable | -$7.5K | $0.00 | |||
| Property Plant And Equipment Net | |||||
| Operating Leases Liability Noncurrent | $17.1K | ||||
| Operating Leases Liability Current | $21.7K | ||||
| Non Cash Transaction Initial Recognition Of Operating Lease Right Of Use Assets And Operating Lease Obligations | |||||
| Non Cash Transaction Finance Lease Liabilities Initial Recognition Of The Balance Payment Of Finance Lease Right Of Use Asset | |||||
| Lease Right Of Use Asset | $38.8K | ||||
| Initial Recognition Of Operating Lease Right Of Use Assets And Operating Lease Obligations | $0.00 | ||||
| Finance Lease Liabilities Initial Recognition Of The Balance Payment Of Finance Lease Right Of Use Asset | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Cash Provided By Used In Operating Activities | -$248.3K |
| Net Cash Provided By Used In Financing Activities | $376.1K |
| Increase Decrease In Inventories | $31.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $29.6K |
| Proceeds From Issuance Of Common Stock | $354.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$2.8K |
| Proceeds From Related Party Debt | $12.8K |
| Increase Decrease In Due To Related Parties | $61.0K |
| Payments For Deposits | $89.2K |
| Increase Decrease In Due To Other Related Parties | |
| Proceeds From Related Party Due To Director | $9.3K |
| Payments To Acquire Property Plant And Equipment | $74.8K |
| Net Cash Provided By Used In Investing Activities | -$74.8K |
| Increase Decrease In Other Receivables | |
| Increase Decrease In Due To Other Related Parties Current | |
| Increase Decrease In Deferred Revenue | |
| Increase Decrease In Accrued Income Taxes Payable | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.8K | -$9.5K |
| Net Cash Provided By Used In Financing Activities | $2.3K | $28.4K |
| Increase Decrease In Inventories | $826.00 | $4.5K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$10.1K | $16.8K |
| Proceeds From Issuance Of Common Stock | $9.0K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | |
| Proceeds From Related Party Debt | $2.3K | |
| Increase Decrease In Due To Related Parties | ||
| Payments For Deposits | ||
| Increase Decrease In Due To Other Related Parties | $5.6K | |
| Proceeds From Related Party Due To Director | ||
| Payments To Acquire Property Plant And Equipment | ||
| Net Cash Provided By Used In Investing Activities | ||
| Increase Decrease In Other Receivables | $23.0K | |
| Increase Decrease In Due To Other Related Parties Current | $13.8K | |
| Increase Decrease In Deferred Revenue | $1.0K | |
| Increase Decrease In Accrued Income Taxes Payable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 23.6M | |
| Earnings Per Share Diluted | $-0.01 | |
| Common Stock Shares Outstanding | 23.7M | 23.5M |
| Common Stock Shares Issued | 23.7M | 23.5M |
| Common Stock Shares Authorized | 200.0M | 200.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 23.7M | 23.5M | 23.5M | 11.7M |
| Earnings Per Share Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 23.7M | 23.5M | 23.5M | |
| Common Stock Shares Issued | 23.7M | 23.5M | 23.5M | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Other Income | $0.00 | |
| Related Party Transaction Due To To Director | $15.6K | $6.2K |
| Additional Paid In Capital | $360.6K | $6.6K |
| Stock Issued During Period Value New Issues | $354.0K | |
| Interest Paid Net | $0.00 | |
| Stock Issued During Period Shares New Issues | 236.0K | |
| Issuance Of Share Capital Private Placement Amount | ||
| Profit And Loss | ||
| Depreciation | $1.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Other Income | $0.00 | $0.00 | $0.00 | $1.00 |
| Related Party Transaction Due To To Director | $7.9K | $7.9K | $6.2K | |
| Additional Paid In Capital | $360.6K | $102.6K | $6.6K | |
| Stock Issued During Period Value New Issues | $265.5K | $88.5K | ||
| Interest Paid Net | $0.00 | $0.00 | ||
| Stock Issued During Period Shares New Issues | ||||
| Issuance Of Share Capital Private Placement Amount | $7.0K | |||
| Profit And Loss | -$175.00 | |||
| Depreciation |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.